Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
Vivos Therapeutics, Inc. (VVOS)
Company Research
Source: GlobeNewswire
LITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (OSA) and snoring in adults and moderate to severe OSA in children ages 6 – 17), today announced it plans to release its full year 2024 financial results after market close on Monday, March 31, 2025. The Company will conduct a conference call at 5:00 p.m. (Eastern Time) on March 31, 2025 to review the results and provide an overview of the Company’s recent milestones and developments.
Read more
Impact Snapshot
Event Time:
VVOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VVOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VVOS alerts
High impacting Vivos Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VVOS
News
- Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational UpdateGlobeNewswire
- The Silent Epidemic: How Women With Obstructive Sleep Apnea (OSA) Are Often Misdiagnosed [Yahoo! Finance]Yahoo! Finance
- The Silent Epidemic: How Women With Obstructive Sleep Apnea (OSA) Are Often MisdiagnosedPR Web
- Vivos Drives Innovation in Chronic Pain Care with Non-Invasive Treatment for Sleep Apnea [Yahoo! Finance]Yahoo! Finance
- Vivos Drives Innovation in Chronic Pain Care with Non-Invasive Treatment for Sleep ApneaPR Web
VVOS
Earnings
- 11/14/24 - Beat
VVOS
Sec Filings
- 3/31/25 - Form 8-K
- 3/31/25 - Form 10-K
- 2/14/25 - Form 424B5
- VVOS's page on the SEC website